UPDATED Aug 11, 2022
Discover large cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 503Lansen Pharmaceutical Holdings | HK$1.37 | -4.9% | -47.5% | HK$576.0m | n/a | PE81.6x | n/a | 0% | ||
| 1498PuraPharm | HK$1.42 | 0% | 71.1% | HK$560.8m | n/a | PB1.4x | n/a | 0% | ||
| 690Uni-Bio Science Group | HK$0.08 | 2.6% | -20.0% | HK$515.5m | n/a | PS1.4x | n/a | n/a | ||
| 8158China Regenerative Medicine International | HK$0.16 | -3.0% | -48.9% | HK$459.5m | n/a | PE9.3x | n/a | n/a | ||
| 897Wai Yuen Tong Medicine Holdings | HK$0.33 | -9.6% | 8.2% | HK$406.4m | n/a | PB0.2x | n/a | 0% | ||
| 455Tianda Pharmaceuticals | HK$0.18 | 0% | -1.6% | HK$397.8m | n/a | PB0.5x | n/a | 1.4% | ||
| 239Pak Fah Yeow International | HK$1.26 | -6.0% | -30.4% | HK$392.7m | n/a | PE10.3x | n/a | 5.2% | ||
| 8225China Health Group | HK$0.31 | -3.1% | -22.5% | HK$308.6m | n/a | PE9x | n/a | n/a | ||
| 1643Modern Chinese Medicine Group | HK$0.44 | 3.5% | -43.6% | HK$276.0m | n/a | PE2.8x | n/a | 3.6% | ||
| 8329Shenzhen Neptunus Interlong Bio-technique | HK$0.15 | -2.6% | -39.8% | HK$266.8m | n/a | PE6.9x | n/a | n/a | ||
| 1889Sanai Health Industry Group | HK$0.086 | 6.2% | n/a | HK$257.6m | n/a | PE25.2x | n/a | 0% | ||
| 1011China NT Pharma Group | HK$0.13 | -1.5% | 28.0% | HK$247.6m | n/a | PE-1.4x | n/a | 0% | ||
| 858Extrawell Pharmaceutical Holdings | HK$0.094 | 17.5% | -13.0% | HK$224.7m | n/a | PE1.7x | n/a | n/a | ||
| 1312Tongfang Kontafarma Holdings | HK$0.039 | -2.5% | -38.1% | HK$218.0m | n/a | PB0.2x | n/a | 0% | ||
| 8247Biosino Bio-Technology and Science Incorporation | HK$1.36 | 0% | 8.8% | HK$196.8m | n/a | PB1x | n/a | 0% | ||
| 575Endurance RP | HK$0.11 | -2.7% | -35.1% | HK$27.6m | n/a | PS2x | n/a | n/a |